Disclaimer: The views and opinions expressed in this article are those of the authors and do not necessarily reflect the official policy or position of Dune Medical.
MarginProbe® Shrinks Positive Margin Rates and Tissue Volume Removed for Both Invasive and DCIS Breast Cancers
Dr. Reid is a firm believer in the success of MarginProbe in improving the results of breast cancer surgery.
Surgeon Spotlight: Dr. Jeffrey Falk – Early Study Data Supports the Value of MarginProbe® in Getting All the Cancer in the First Lumpectomy Surgery
Dr. Jeffrey Falk is a surgical oncologist focusing primarily on breast cancer since starting his practice in 2001. He performs 200-350 breast cancer surgeries annually and has a special interest in research and clinical trials for breast cancer treatments.